Skip to main content

Entrada Therapeutics, Inc. (TRDA)

Entrada Therapeutics will go public soon. The estimated IPO date is October 29, 2021.
Stock Price: $19.00 - $21.00
Current IPO price range
Chart not available yet
Data will show when the stock starts trading on Oct 29, 2021.
Market Cap566.25M
Revenue (ttm)n/a
Net Income (ttm)-33.94M
Shares Out28.31M
EPS (ttm)-1.20
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Openn/a
Previous Closen/a
Day's Rangen/a
52-Week Rangen/a
Betan/a
Analystsn/a
Price Targetn/a
Earnings Daten/a

About TRDA

Entrada Therapeutics aims to transform the lives of patients by establishing Endosomal Escape Vehicle (EEV) therapeutics as a new class of medicines and aims to become the world’s foremost intracellular therapeutics company. Our EEV therapeutics are designed to engage intracellular targets that have long been considered inaccessible and undruggable. Through our proprietary, highly versatile and modular EEV platform, we are building a robust development portfolio of EEV therapeutic candidates designed to enable the efficient intracellular deli...

IndustryBiotechnology
IPO DateOct 29, 2021
CEODipal Doshi
Employees78
Stock ExchangeNASDAQ
Ticker SymbolTRDA
Full Company Profile

Financial Performance

Financial Statements

News

Rare disease biotech Entrada Therapeutics files for a $100 million IPO

Entrada Therapeutics, a preclinical biotech developing therapies for rare neuromuscular diseases, filed on Friday with the SEC to raise up to $100 million in an initial public offering.

2 weeks ago - Renaissance Capital

Entrada Therapeutics IPO Registration Document (S-1)

Entrada Therapeutics, Inc. has filed to go public with an IPO on the NASDAQ.

2 weeks ago - SEC